NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis.

Christian M. Kurbacher,Thomas Fietz,Ingo J. Diel,Matthias Egert,Hans-Jürgen Hurtz,Andreas Lück,Rudolf Weide,Christoph Salat,Thomas Wolff,Matthias Zaiss,Peter Klare,Christoph Losem,Thomas Illmer,Georg Weißenborn,Claus-Christoph Steffens,Matthias Schulze,Hans Tesch,Gülten Oskay-Oezcelik,Beate Teichmann,Johanna Harde,Robert Willy Scheuerlein

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis.

2015

Background: The non-interventional study (NIS) NADIRwas designed to assess the effectiveness and safety of lipegfilgrastim, a novel glycopegylated granulocyte-co

Keywords:

General surgery
Neutropenia
Febrile neutropenia
Granulocyte colony-stimulating factor
Interim analysis
Medicine
Intensive care medicine
Nadir
Internal medicine
Lipegfilgrastim
Chemotherapy
Breast cancer
Interquartile range
Adverse effect

Correction
Source
Cite
Save

References

Citations